NCT00122187

Brief Summary

Colorectal cancer (CRC) is the second leading cause of cancer-related deaths in the United States. Results from randomized clinical trials and intervention studies have suggested that implementation of a CRC screening program for men and women over age 50 results in reduced CRC mortality. However, for this reduction to be fully realized, it is imperative that all positive screening tests are followed by complete diagnostic evaluation (CDE). Numerous intervention programs have been used to improve initial CRC screening rates, but data indicate that outside the research setting, less than half of patients with a positive fecal occult blood test (FOBT) screening result undergo CDE. To enhance the translation of this best practice recommendation to clinical practice, the investigators propose to implement an electronic event notification intervention (CRC-ENS) directed at making physician and system level changes to increase the proportion of patients with an abnormal FOBT that undergo CDE.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
8

participants targeted

Target at below P25 for not_applicable colorectal-cancer

Timeline
Completed

Started Aug 2005

Typical duration for not_applicable colorectal-cancer

Geographic Reach
1 country

9 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 18, 2005

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 21, 2005

Completed
11 days until next milestone

Study Start

First participant enrolled

August 1, 2005

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2008

Completed
5.7 years until next milestone

Results Posted

Study results publicly available

January 27, 2014

Completed
Last Updated

April 24, 2015

Status Verified

September 1, 2013

Enrollment Period

2.8 years

First QC Date

July 18, 2005

Results QC Date

December 5, 2013

Last Update Submit

April 6, 2015

Conditions

Keywords

cancercolonoscopymass screeningcolorectal cancercolorectal carcinomareminder systemsrectal cancerscolorectal tumorguidelinesCRC secondary preventioncolorectal neoplasmscolonic neoplasmscolonic diseaseshemoccult testing

Outcome Measures

Primary Outcomes (2)

  • Percent of Patients Receiving GI Consult for FOBT+ Results

    Percent of patients receiving GI consult within 30, 90, and 180 days of FOBT+ results

    6 months

  • Percent of Patients Receiving GI Consult Plus Anatomic Workup for FOBT+ Results

    Percent of patients receiving GI consult plus anatomic workup within 30, 90, and 180 days of FOBT+ results

    6 months

Study Arms (2)

Electronic Consult System

EXPERIMENTAL

A new consult system designed to automatically send a gastroenterology consult request for patients with positive fecal occult blood testing (FOBT+) results

Device: Electronic Consult System

Usual Care

NO INTERVENTION

The usual and customary procedures for addressing FOBT+ results: primary care physicians continued to be responsible for follow up of FOBT+ results.

Interventions

Consult system is an event notification system programmed to function within the VA electronic medical record system.

Electronic Consult System

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • \- VA Medical Centers with either CORI (Clinical Outcomes Research Initiative) or electronic notes/descriptions documenting GI endoscopic procedures

You may not qualify if:

  • \- VA Medical Centers without electronic GI procedure documentation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (9)

Phoenix VA Health Care System, Phoenix, AZ

Phoenix, Arizona, 85012, United States

Location

Southern Arizona VA Health Care System

Tucson, Arizona, 85723, United States

Location

VA Eastern Colorado Health Care System, Denver, CO

Denver, Colorado, 80220, United States

Location

Overton Brooks VA Medical Center

Shreveport, Louisiana, 71101-4295, United States

Location

Minneapolis

Minneapolis, Minnesota, 55417, United States

Location

Durham VA Medical Center, Durham, NC

Durham, North Carolina, 27705, United States

Location

VA Portland Health Care System, Portland, OR

Portland, Oregon, 97239, United States

Location

Tennessee Valley Healthcare System Nashville Campus, Nashville, TN

Nashville, Tennessee, 37212-2637, United States

Location

VA Medical & Regional Office Center, White River

White River Junction, Vermont, 05009-0001, United States

Location

Related Publications (3)

  • Tsai TT, Nallamothu BK, Prasad A, Saint S, Bates ER. Clinical problem-solving. A change of heart. N Engl J Med. 2009 Sep 3;361(10):1010-6. doi: 10.1056/NEJMcps0903023. No abstract available.

  • Messersmith WA, Ahnen DJ. Targeting EGFR in colorectal cancer. N Engl J Med. 2008 Oct 23;359(17):1834-6. doi: 10.1056/NEJMe0806778. No abstract available.

  • Humphrey LL, Shannon J, Partin MR, O'Malley J, Chen Z, Helfand M. Improving the follow-up of positive hemoccult screening tests: an electronic intervention. J Gen Intern Med. 2011 Jul;26(7):691-7. doi: 10.1007/s11606-011-1639-3. Epub 2011 Feb 15.

MeSH Terms

Conditions

Colorectal NeoplasmsNeoplasmsRectal NeoplasmsColonic NeoplasmsColonic Diseases

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteDigestive System DiseasesGastrointestinal DiseasesIntestinal DiseasesRectal Diseases

Limitations and Caveats

Half of the sites randomized did not complete the study. GI referral rates should have been nearly 100%, yet were not. Because of programming limitations, we were unable to evaluate the type of diagnostic interventions the patients received.

Results Point of Contact

Title
Linda Humphrey
Organization
VAHSRD

Study Officials

  • Linda L. Humphrey, MD MPH

    VA Portland Health Care System, Portland, OR

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 18, 2005

First Posted

July 21, 2005

Study Start

August 1, 2005

Primary Completion

May 1, 2008

Study Completion

May 1, 2008

Last Updated

April 24, 2015

Results First Posted

January 27, 2014

Record last verified: 2013-09

Locations